Krawczyk , P. “Role of Molecular Examinations in Qualification to First Line Treatment With Erlotinib in NSCLC Patients Based on EUTARCstudy Results”. OncoReview, Vol. 3, no. 1(9), Mar. 2013, pp. 26-33, https://journalsmededu.pl/index.php/OncoReview/article/view/332.